Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

Creative Commons License

Hatemi G. , Ozguler Y. , Direskeneli H., Mahr A., GÜL A., LEVI V., ...Daha Fazla

The Journal of rheumatology, cilt.42, sa.12, ss.2436-41, 2015 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 42 Konu: 12
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3899/jrheum.141147
  • Dergi Adı: The Journal of rheumatology
  • Sayfa Sayıları: ss.2436-41


Objective. There is an unmet need for reliable, validated, and widely accepted outcomes and outcome measures for use in clinical trials in Behcet syndrome (BS). Our report summarizes initial steps taken by the Outcome Measures in Rheumatology (OMERACT) vasculitis working group toward developing a core set of outcome measures for BS according to the OMERACT methodology, including the OMERACT Filter 2.0, and discussions during the first meeting of the BS working group held during OMERACT 12 (2014).